About
Matis Medical's Cone and Plate(let) Analyzer (CPA) is a point-of-care system for real-time, whole-blood platelet function testing. The company's first two products are the Impact and the Impact-R. The company has performed an extensive body of studies that demonstrated the Impact's success in screening forcongenital primary hemostasis abnormalities and testing platelet response to GPIIb-IIIa antagonists, aspirin, and clopidogrel. The Impact system for clinical and point-of-care laboratories is in development and is not commercially available. Matis Medical was founded in 2000. The CPA technology was invented by Prof. David Varon and Prof. Naphtali Savion and patented through Ramot, the Authority for Applied Research & Industrial Development of the Tel Aviv University, Israel. Ramot granted Matis Medical exclusive rights for the worldwide commercialization of the technology for all applications.